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Abstract We previously reported that the rat aldolase C 115 bp
promoter is sufficient to ensure the brain specific expression of
the chloramphenicol acetyltransferase reporter gene in trans-
genic mice. We identify in a further reduced 84 bp promoter
several putative binding sites for the transcriptional factors Sp1,
USF, AP1, and AP2. Deletion or mutation of these partially
overlapping binding sites results in inactivation of the cognate
transgenes. Moreover, we show that the 115 bp sequence is able
to direct bidirectional transcription in vivo but, surprisingly,
transcriptional activity in the opposite direction is no more brain
specific. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Fructose 1,6-diphosphate aldolase C is a glycolytic enzyme
strongly and speci¢cally expressed in adult brain. We previ-
ously reported that (i) in spite of its tissue speci¢city, the rat
aldolase C gene promoter displays features of housekeeping
genes (absence of TATA and CAAT sequences, presence of
G+C rich elements and multiple transcription start sites dis-
persed over about 100 nucleotides [1], (ii) a short 115 bp
promoter fragment is able to ensure, at a low level, the speci¢c
expression of the chloramphenicol acetyltransferase (CAT)
reporter gene in the brain of transgenic mice [2]. Moreover,
the two GC rich regions (A/AP and B boxes) de¢ned by foot-
printing experiments in this 115 bp fragment being function-
ally redundant in vivo [3], the minimal brain speci¢c promot-
ing region was further reduced to 84 bp. Therefore, we
considered the rat aldolase C promoter as an appropriate
tool to investigate the still poorly understood molecular events
underlying the brain speci¢c expression of neuronal genes. In
this paper, we report the identi¢cation of several partially
overlapping transcription factor binding sites in the 84 bp
promoter and the in vivo analysis of various modi¢ed trans-
genes containing mutation, deletion, or multimerization of
some of these sites. All analyzed mutant transgenes were
found to be inactive in vivo. We also cloned the initially
described 115 bp promoter in an inverted orientation up-
stream of the CAT reporter gene and obtained active trans-
genic lines demonstrating that the TATA-less rat aldolase C
promoter displays a bidirectional activity. However, while this
promoter fragment confers a brain speci¢city on the reporter
gene in the forward orientation, it behaves nearly as an ubiq-
uitous promoter in the backward orientation. This suggests
that the spatial arrangement of the di¡erent regulatory pro-
teins on the promoter could constitute an additional level of
complexity in brain speci¢c gene expression.
2. Materials and methods
2.1. Plasmid constructions
The 115/CAT, 84/CAT (3167/384, previously noted B/C/CAT),
and hepatocyte nuclear factor (HNF)mut/CAT constructs have been
described previously [2,3]. The 76 bp fragment (3159/384) was pre-
pared by polymerase chain reaction (PCR) and cloned upstream of
the CAT reporter gene, resulting in the 76/CAT construct. Box B mut/
84/CAT and Homol mut/84/CAT constructs correspond to the 84/
CAT transgene where sequences CGCCC (3150/3146) and GGAGT
(3141/3137) were mutated by PCR to GAATT and AATTC, respec-
tively. The 6(Sp1B)/76/CAT was obtained by inserting a multimer of
the Sp1B site upstream of the 76 bp fragment in the 76/CAT con-
struct. The transgene 115 inv/CAT was prepared by cloning the 115
bp fragment in the inverted orientation upstream of the CAT reporter
gene.
2.2. Brain nuclear extracts
Nuclear extracts were prepared from rat brain according to Piette et
al. [4] and from HeLa cells according to Dignam et al. [5].
2.3. Electrophoretic mobility shift assays (EMSAs)
Oligonucleotides used as probes or competitors were: Intermediate,
5P-CCAGGATGGGAGGTGTCTGTCACGC-3P (3172/3148), Box
B, 5P-GATGGGAGGTGTCTGTCACGCCCCCAGGGAGTC-3P
(3168/3136), Box B mut, 5P-GATGGGAGGTGTCTGTCAGAA-
TTCCAGGGAGTC-3P (nucleotides 3150/3146 mutated), Homolog,
5P-CAGGGAGTCACGTAGCTCTGCGGCAT-3P (3144/3119), Ho-
mol mut 5P-CAGAATTCCACGTAGCTCTGCGGCAT-3P (nucleo-
tides 3141/3137 mutated) derived from the rat aldolase C gene;
Sp1cons, 5P-CTAACTGGGCGGAGTTATGC-3P (derived from the
simian virus 40 enhancer) [6]; MLP, 5P-GGAACACCCGGTCA-
CGTGGCCTACACCT-3P (derived from the Adenovirus major late
promoter (MLP)) [7]; hMtII 5P-AACTGACCGCCCGCGGCCCGT-
3P (derived from the human metallothionein IIa gene) [8].
EMSAs were performed as previously described[3,9]. Binding reac-
tions contained 7^10 Wg of nuclear extract proteins or 0.125 footprint
unit of the recombinant human Sp1 protein (Promega) with 300 ng of
poly(dIdC) or 1 Wg of sonicated salmon sperm DNA and 0.1^0.5 ng
of T4 kinase-radiolabeled double-stranded probe. When added, com-
petitors were present at a 200-fold molar excess. For supershift assays,
binding reactions were incubated for 30 min at 4‡C as usually, then
supplemented with 1 or 2 Wl of antibodies and further incubated for
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30 min at 4‡C. Free and bound DNAs were separated on non-denat-
uring 6% (w/v) polyacrylamide gels. Polyclonal anti-upstream stim-
ulatory factor 1 (USF1) antibodies were kindly provided by M. Ray-
mondjean [10]. Polyclonal anti-AP2 antibodies were supplied by
Santa-Cruz Biotechnology, Inc.
2.4. Production and analysis of transgenic mice
Inserts were isolated from agarose gels and puri¢ed on Elutip-d
columns (Shleicher and Schuell). The fragments (5^10 ng in a
10 mM Tris^HCl, pH 7.5, 0.1 mM EDTA bu¡er) were microinjected
into fertilized B6D2 mouse eggs [11]. Transgenic founders and o¡-
spring were identi¢ed [12] by Southern blot using a random-primed
CAT probe. CAT activities generated by transgene expression were
assayed on 200^500 Wg of brain, liver, heart and lung extract proteins
[13].
3. Results and discussion
3.1. In vitro and in vivo analysis of the 84 bp promoter
In a previous study concerning functional dissection of the
115 bp rat aldolase C promoter, we reported that the two GC
rich A/AP and B boxes were functionally redundant in vivo
and that a promoter including either the A/AP or the B box
linked to the C box (characterized by a dual speci¢city for
both POU domain regulatory proteins and the Winged Helix
HNF3L) [14] is su⁄cient to ensure a brain speci¢c CAT ac-
tivity in transgenic mice (transgene B/C/CAT in [3], denoted
84/CAT in this paper). We then focused our study on the
84 bp promoter encompassing boxes B and C (Fig. 1). This
84 bp sequence retained two already described binding sites
for the factor Sp1, Sp1i (located in the sequence Intermediate,
between A/AP and B boxes) and Sp1B (located in the B box)
(Fig. 1 and Fig. 2A, lanes 1^4), and a binding site for two
widespread expressed unidenti¢ed proteins X and Y [2]. In
addition, computer analysis and EMSA studies allowed us
to identify other DNA/protein interactions. Overlapping ho-
mologies with consensus binding sites for the factors USF and
AP1 are present both in box B (USFB and AP1B) and in a
short sequence of 19 bp perfectly conserved between the rat
and human aldolase C genes, called Homolog (USFH and
AP1H) (Fig. 1). The binding of USF to oligonucleotides Box
B and Homolog was con¢rmed by EMSA using as competitor
the Adenovirus MLP binding site [7] and anti-USF1 antibod-
ies (Fig. 2B, lanes 6^10); the same result was obtained with
anti-USF2 antibodies (not shown). Binding of AP1 to so-
called AP1B and AP1H sites was also con¢rmed using the
oligonucleotides Box B and Homolog which were found
able to compete weakly in EMSA with the binding of AP1
complexes from a brain extract to the speci¢c AP1 binding
element of the human collagenase gene [15] (not shown). The
predicted interaction with the embryonic protein AP2 could
not be detected with adult brain extracts; however, the oligo-
nucleotide Box B was able to compete with the binding of the
factor AP2 from a HeLa cell extract to the DNA probe hMtII
[8] representing the AP2 binding site of the human metallo-
thionein gene (Fig. 2C, lanes 13^16). This AP2 motif could be
involved in the weak but ubiquitous expression of aldolase C
in embryonic tissues [16]. Finally, a low a⁄nity binding site
for the factor YY1 [17] was also observed in vitro on box C
(not shown).
In order to identify critical DNA elements required for the
brain speci¢city of the 84 bp promoter, various mutant ver-
sions of the 84/CAT wild-type transgene were analyzed in vivo
in transgenic mice (Table 1). The Box B mut/84/CAT trans-
gene, where mutation of ¢ve nucleotides in Box B suppressed
the binding of Sp1 (Fig. 2A, lane 5), USF (Fig. 2B, lane 12),
AP1, and AP2 (not shown), was totally inactive. Deletion of
the upstream Sp1i binding site in the 76/CAT construct also
Fig. 1. Protein binding sites in the 84 bp aldolase C promoter. The B and C footprinted boxes described in [3] and the 19 bp homolog between
the rat and human genes are indicated by arrows. Bases mutated in Box B mut/84/CAT, Homol mut/84/CAT, and HNF mut/CAT transgenes
are indicated by boldface letters. Already reported and newly identi¢ed protein binding sites are presented above and under the aldolase C se-
quence, respectively.
Table 1
Mutations in the 84 bp promoter
Transgene Altered binding sites Range of CAT activity in brain
84/CATa [3] wild type 4^39
Box B mut/84/CAT Sp1B, USFB, AP1B, AP2 mutated 6 0.02
76/CAT Sp1i deleted 6 0.02^0.03
6(Sp1B)/76/CAT Sp1i deleted, 6(Sp1B) inserted 6 0.02^0.05
Homol mut/84/CAT AP1H, USFH mutated 6 0.02^0.05
HNF mut/CAT[3] HNF3L mutated 6 0.02
aThe 84/CAT transgene corresponds to the previously described B/C/CAT construct in [3]. CAT activities are expressed in cpm min31 Wg
protein31. For each transgene, 6^15 lines or founders were analyzed.
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abolished or drastically reduced CAT activity. However, in-
sertion of six Sp1B sites upstream of the inactive 76 bp frag-
ment, resulting in the transgene 6(Sp1B)/76/CAT, did not re-
store CAT expression in the brain of transgenic mice.
Therefore binding of Sp1 molecules is not su⁄cient for tran-
scriptional activity and DNA interaction with other regula-
tory proteins probably occurs upstream of and in the B box.
Finally, substitution of ¢ve nucleotides at the 5P-end of the
Homolog element, abolishing the binding of USF (Fig. 2B,
lane 11) and of AP1 (not shown) in this region, resulted in the
inactive transgene Homol mut/84/CAT. We already reported,
in the context of the 115 bp promoter, that destruction of the
HNF3L binding site (transgene HNF mut/CAT) also abol-
ished CAT activity [3]. This result was not due to the loss
of interaction with POU factors or YY1 since in vitro a⁄nity
for these proteins was rather enhanced in the mutated se-
quence (not shown).
In conclusion, each of the four binding sites Sp1i, Sp1B/
USFB/AP1B/AP2, USFH/AP1H, and HNF3L/POU/YY1 seems
to be critical for transcriptional activity of the rat aldolase C
promoter. It was therefore impossible, on basis of these data,
to attribute the brain speci¢city of the 84 bp promoter to
precise DNA elements. It is probable that multiple interac-
tions on this short sequence contribute to a complex and
‘minimal’ array that cannot be altered further without losing
its promoter activity.
3.2. The rat aldolase C promoter is bidirectional
A number of promoters lacking a TATA box and an ini-
tiator element display a bidirectional activity [18^24]. We ex-
amined whether the brain speci¢c rat aldolase C promoter
exhibits the same characteristic. The 115 bp promoter was
cloned in the inverted orientation upstream of the CAT re-
porter gene and expression of the 115 inv/CAT resulting
transgene was analyzed in di¡erent tissues for eight transgenic
founders (Table 2). Two of them (animals 19 and 24) re-
mained silent (as already reported for CAT/aldolase C chi-
meric constructs, transgene expression was dependent on the
integration site, [25]). Five founders (animals 3, 5, 6, 8, and
34) presented a CAT activity not only in brain but also in
lung and heart; transgenes were always inactive in liver.
Spleen was also assayed in animal 34 and was found positive
for CAT expression. Except for the founder 3, levels of CAT
activity were similar in lung and brain, but weaker in heart.
Finally, founder 27 was the only one where CAT activity was
detected in brain and not in other tissues. We can notice that
the 115 bp promoter has approximately the same strength
whether inserted in the forward or backward orientation
(see Table 2 and legend).
Thus we can conclude that the 115 bp aldolase C promoter
is able to drive bidirectional transcription in vivo. A number
Fig. 2. EMSA analysis of the 84 bp promoter. EMSAs were per-
formed as described in Section 2. A: The radiolabeled Sp1cons oli-
gonucleotide was incubated with recombinant human Sp1 protein.
B: The radiolabeled Homolog oligonucleotide was incubated with a
rat brain nuclear extract. C: The radiolabeled hMtII oligonucleotide
was incubated with a HeLa cell nuclear extract. The arrows indicate
position of speci¢c (speci¢cally displaced by cognate competitor)
and non-speci¢c (ns) (non displaced) complexes. The indicated com-
petitors were present at a 200-fold molar excess. Addition of anti-
USF1 (1 Wl, lane 10) and anti-AP2 (2 Wl, lane 14) antibodies re-
sulted in reduction of the speci¢c bands without appearance of
supershifted complexes. In each case, this inhibition was controlled
to be speci¢c since the anti-USF and anti-AP2 antibodies were
found unable to inhibit the binding of the unrelated proteins AP1
and Sp1, respectively, to their cognate sites (not shown).
Table 2
Bidirectional activity of the 115 bp promoter
The brain CAT activities directed by the wild type construct 115/
CAT in four transgenic lines were: 0.04, 1.1, 1.4 and 1.5 cpm
min31 Wg protein31 [2]. nd: not determined.
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of TATA-less promoters have been reported to direct diver-
gent transcription of two genes located head-to-head on a
chromosome [18,21^24]. In some cases, they rather appear
as the overlap of two distinct promoters with shared DNA
elements but distinct regulation features [21,22] ; in other
cases, the model of a single integrated bidirectional promoter
has been proposed, providing for a mechanism of coregula-
tion as for two chicken genes encoding enzymes of the same
biosynthetic pathway [18]. In the case of the aldolase C gene,
computer research did not revealed any open reading frame in
the opposite direction in the 5.5 kb sequences available up-
stream of the promoter. For the bidirectional thymidine syn-
thase promoter, transcription of upstream transcripts from the
opposite strand of the DNA has been shown but presumably
without any functional signi¢cance [19]. We can hypothesize
that the lack of TATA and initiator elements that would
specify transcriptional orientation and the presence of sym-
metrical binding sites such as GC boxes represent features
that allow the transcriptional machinery to function in both
orientations. Indeed, in the aldolase C 115 bp promoter as in
most bidirectional promoters so far reported, one or several
Sp1 binding sites occurred [18,20^24]. The presence of two
USF binding sites in the 115 bp fragment could also be in-
volved in the observed bidirectional activity. In the transco-
balamin II promoter gene, a USF binding motif alone has
been shown to direct bidirectional transcription, presumably
by recruiting or stabilizing the binding of components of the
basal transcription machinery [20].
The most interesting feature of the aldolase C promoter
activity is that inverting its orientation modi¢es the pattern
of expression of the reporter gene in the di¡erent tissues an-
alyzed. The rat insulin II gene promoter was also shown to
function in both orientations in vivo in transgenic mice but
with the same tissue speci¢city [26]. However, in this latter
study, a large fragment (720 bp including enhancer plus pro-
moter sequences) was inserted in the opposite orientation. In
contrast, the strict brain speci¢city of the 115 bp aldolase C
promoter in its natural orientation was lost in ¢ve out of six
active mouse transgenic lines when it was inserted in the re-
verse orientation. The only case in which the promoter in the
backward orientation was active in brain and not in other
tissues could correspond to insertion of the transgene in the
vicinity of a transcription unit active in the brain.
In conclusion, we have shown by our mutagenesis experi-
ments that brain speci¢city of the 84 bp minimal active pro-
moter fragment requires integrity of all of its DNA elements
and therefore could be combinatorial in nature. The in£uence
of the promoter orientation on its speci¢city of expression
indicates that the brain speci¢city depends not only on mutual
interaction between the di¡erent DNA elements and cognate
DNA binding proteins but also on the orientation of these
elements with respect to the sense of transcription. This in-
formation should be taken in consideration for further inves-
tigation on molecular mechanisms involved in regulation of
brain speci¢c gene expression.
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